← Back to Search

Procedure

Electrophysiological Imaging for Ventricular Tachycardia (ECGI-VT Trial)

N/A
Recruiting
Led By John L Sapp, MD FRCPC
Research Sponsored by John Sapp
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Referred for catheter ablation
One or more episodes of sustained monomorphic VT
Timeline
Screening 3 weeks
Treatment Varies
Follow Up less than 6 months post procedure
Awards & highlights

ECGI-VT Trial Summary

This trial is testing a new way to map and treat ventricular tachycardia, which contributes to over 350,000 sudden deaths each year in the US. The new method uses catheter ablation to "block" the channel that forms the circuit, with guidance from 3D images. The hope is that this will improve ablation efficacy and help clinicians identify ablation targets and assess ablation outcome.

Who is the study for?
This trial is for individuals who have had a heart attack or suffer from rapid, irregular heartbeats known as ventricular tachycardia and are scheduled for catheter ablation. Participants must have experienced sustained VT episodes, have an implantable cardioverter-defibrillator (ICD), and be able to follow the study's procedures. People with severe kidney issues, short life expectancy, listed for heart transplant, pregnant women, those on certain heart medications or with conditions that prevent MRI or CT scans cannot join.Check my eligibility
What is being tested?
The trial is testing EP Imaging and Testing to improve treatment of ventricular tachycardia by using advanced imaging techniques combined with standard care. The goal is to better identify where in the heart's tissue electrical 'short circuits' occur before and after procedures like catheter ablation.See study design
What are the potential side effects?
While specific side effects are not detailed here, typical risks may include discomfort at the imaging site, potential allergic reactions to contrast materials used in CT/MRI scans if applicable, and general risks associated with catheter ablation such as bleeding or infection.

ECGI-VT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am referred for a procedure to treat heart rhythm problems.
Select...
I have had one or more episodes of a specific type of irregular heartbeat.

ECGI-VT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~less than 6 months post procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and less than 6 months post procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Termination of Ventricular Tachycardia
VT recurrence rate

ECGI-VT Trial Design

1Treatment groups
Experimental Treatment
Group I: EP Imaging and TestingExperimental Treatment1 Intervention
MRI images,120 lead body surface mapping and NIPS testing will be completed to correlate areas of VT scar.

Find a Location

Who is running the clinical trial?

John SappLead Sponsor
5 Previous Clinical Trials
712 Total Patients Enrolled
Nova Scotia Health AuthorityOTHER
255 Previous Clinical Trials
83,619 Total Patients Enrolled
Rochester Institute of TechnologyOTHER
9 Previous Clinical Trials
4,799 Total Patients Enrolled

Media Library

EP Imaging and Testing (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT03713866 — N/A
Ventricular Tachycardia Research Study Groups: EP Imaging and Testing
Ventricular Tachycardia Clinical Trial 2023: EP Imaging and Testing Highlights & Side Effects. Trial Name: NCT03713866 — N/A
EP Imaging and Testing (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03713866 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities to join this research endeavor?

"Clinicaltrials.gov reveals that this study is currently enrolling patients, having been published on November 1st 2019 and recently updated as of March 14th 2022."

Answered by AI

Is eligibility for this trial restricted to individuals over the age of forty?

"This clinical trial is open to individuals aged 18 and older, up to 85 years of age."

Answered by AI

What is the maximal capacity of participants permitted in this trial?

"Affirmative. As evidenced on clinicaltrials.gov, the trial that was initially published on November 1st 2019 is actively seeking participants; 20 patients must be sourced from one centre."

Answered by AI

Would I be an eligible participant for this clinical experiment?

"Exclusively for those aged 18 to 85 who have suffered from myocardial infarction, this clinical trial is open to a maximum of 20 individuals."

Answered by AI
~4 spots leftby Mar 2025